Similar benefits with ACE inhibition in CAD patients were seen in the EURopean trial On Reduction of cardiac events with Perindopril in stable coronary Artery disease (EUROPA)[34] and the Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)[35]. The gene discussed is ACE; the disease is coronary artery disorder.